| |
Overview
Dermatology Associates clinical research
facility is a provider of Phase II through Phase
IV dermatology trials. We are dedicated to
conducting the highest quality of clinical
research. Dermatology Associates has been
actively participating in clinical trials since
2004. Dr. Bernard Goffe has been participating
in clinical research for nearly 25 years. His
predominant research focus lies in psoriasis, a
chronic skin condition characterized as a
non-contagious inflammatory skin disease
characterized by recurring reddish patches
covered with silvery scales. He is well known
for his efforts in the diagnosis and treatment
of psoriasis. Dr. Goffe along with
rheumatologist Dr. Philip Mease are well known
for their published work in the Lancet; "Etanercept
in the Treatment of Psoriatic Arthritis," 2000.
Dr. Goffe has also played an instrumental role
in clinical trials involving
Enbrel in
the treatment of Psoriasis. In February 2004,
Enbrel
received FDA approval for the treatment of
Psoriasis. Dr. Goffe also has experience in
the use of other conventional and new biological
treatments such as topical steroids, oral
retinoids, Methotrexate, PUVA,
Remicade,
Raptiva
and Amevive.
Dr. Peter Jenkin began his research
experience in the 80s participating in topical
clinical trials for antibiotics for acne and
antifungal conditions. His research focus is on
acne, Rosacea, Atopic Dermatitis, skin cancer
and cosmetics.
Both Doctors are actively involved in all our
current clinical trials as either Primary
Investigator or Sub-Investigator. We encourage
you to review each of their Curriculum Vitae for
a more complete history.
If you are interested in learning more about
our research, please contact our clinic at (206)
267.2100, or email us at
info@DASeattle.com.
^ Top
|
|
